From: Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
Input | Value* | Reference |
---|---|---|
Baseline demographic characteristics | Â | Â |
Current age (years, mean ± SD) | 64 ± 10 | |
Women (%) | 47 | |
Diabetes duration (years, mean ± SD) | 10.5 ± 9.2 | |
Height (m, mean ± SD) | 1.52 ± 0.11 | |
Smokers (%) | 33 | |
Modifiable CVRF | Â | Â |
HbA1c (%, mean ± SD) | 7.7 ± 1.8 | |
Total cholesterol (mmol/l, mean ± SD) | 5.2 ± 0.98 | |
HDL-cholesterol (mmol/l, mean ± SD) | 1.2 ± 0.4 | |
SBP (mm Hg, mean ± SD) | 131 ± 15 | |
Weight (kg, mean ± SD) | 70,8 ± 9,1 |